NEOGENOMICS INC — Director's Dealing 2015

Apr 24, 2015

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2015-04-16

Reporting Person: BALLIET JENNIFER (Vice President Human Resources)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	465	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$1.45	2016-05-20	Common Stock (3334)		Direct
Stock Option (Right to Buy)	$1.1	2016-10-14	Common Stock (3334)		Direct
Stock Option (Right to Buy)	$1.69	2017-04-12	Common Stock (6250)		Direct
Stock Option (Right to Buy)	$3.76	2018-04-16	Common Stock (7500)		Direct
Stock Option (Right to Buy)	$3.45	2019-03-05	Common Stock (15000)		Direct

Footnotes

F1: On May 20, 2011 Jennifer Balliet was granted 10,000 stock options. The options vested ratably over the first three anniversary dates of the grant date. Jennifer exercised 6,666 of these options and she currently has 3,334 options available to exercise.

F2: On October 14, 2011 Jennifer Balliet was granted 10,000 stock options. The options vest ratably over the first three anniversary dates of the grant date. Jennifer Balliet exercised 6,666 options from this grant and has 3,334 options available to be exercised.

F3: On April 12, 2012 Jennifer Balliet was granted 12,500 stock options. One quarter of these options vested immediately and the remaining options vested on the next three anniversary dates of the grant date. Jennifer Balliet has exercised 6,250 stock options from this grant and has 6,250 stock options available to be exercised.

F4: On April 16, 2013 Jennifer Balliet was granted 7,500 stock options. The options vest ratably over the first three anniversary dates of the grant date.

F5: On March 5, 2014 Jennifer Balliet was granted 15,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.